Q&As

Filter By:

Article Type
  • Krystal Vasquez, PhD student at Caltech, talks to Nature Chemistry about her experiences as an atmospheric researcher — both in the lab with her favourite instruments and in the scientific community as a disabled scientist — as well as her love for science writing.

    • Anne Pichon
    Q&A
  • Gemma Tracey talks to Nature Chemistry about ingrained inequalities in the research community and the role of funders in replacing privilege with equitable and transparent systems.

    • Anne Pichon
    Q&A
  • The career paths of Alveda Williams and Cory Valente have closely mirrored each other — perhaps surprisingly so for a straight Black woman and a gay white man with very different childhoods. They talk to Nature Chemistry about their journeys from research and development roles to Dow’s inclusion and diversity team.

    • Anne Pichon
    Q&A
  • Ayanna Jones, Samantha Mensah and Devin Swiner, three of the #BlackInChem co-founders, talk to Nature Chemistry about the origins, goals, initiatives and joy of this movement.

    • Anne Pichon
    Q&A
  • Manza B. J. Atkinson talks to Nature Chemistry about his path to become a chemist, and how he applies the scientific method to all aspects of his life — from financial analysis to coaching youth sports teams.

    • Anne Pichon
    Q&A
  • Yujia Qing, an early-career researcher at the University of Oxford, talks to Nature Chemistry about winning the Dream Chemistry Award 2019, her chemistry dream of ‘Sequencing Life’, and the challenge this represents.

    • Russell Johnson
    Q&A
  • Dave Laffan, a Director in Chemical Development at AstraZeneca, talks to Nature Chemistry about safety in industry labs and his role on the Safety, Health and Environment committee.

    • Katherine Geogheghan
    Q&A
  • Marc Reid, a researcher at the University of Strathclyde and co-founder of Pre-Site Safety, talks to Nature Chemistry about safety, both as an academic scientist and as a director of a safety-focused company.

    • Katherine Geogheghan
    Q&A
  • Jadambaa Khuyagbaatar from the Helmholtz Institute Mainz and the GSI Helmholtz Centre for Heavy Ion Research talks to Nature Chemistry about superheavy element studies and why creating and exploring these fleeting nuclei matters.

    • Anne Pichon
    Q&A
  • Ghotas Evindar, Chemistry Group Leader at GlaxoSmithKline, talks with Nature Chemistry about the advantages of using encoded libraries in drug discovery and the challenges these technologies present.

    • Russell Johnson
    Q&A